September 12, 2018 Clinical Research/Diagn. Licensing, IP, and Legal

Quanterix Announces Termination of License Agreement With Biomérieux

Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.–(BUSINESS WIRE)–Sep. 12, 2018– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination... Read more

September 11, 2018 Lab Equipment Product Launch

Heathrow Scientific Introduces a High Performance Magnetic Induction Stirrer (motor-less) to its Laboratory Equipment Line

http://www.heathrowscientific.com/medias/Magnetic%20Induction%20Stirrer%20Press%20Release%20s.pdf Erin Hankforth Director of Marketing Ph: 847-968-5991 E-mail: ehankforth@heatsci.com www.heathrowscientific.com September 11, 2018 Vernon Hills, IL, September 11, 2018 – Heathrow Scientific, a leader in manufacturing bench top equipment and lab essentials for scientific and clinical markets announces the introduction of a Magnetic Induction Stirrer (3 liter plus) to their laboratory equipment line. The... Read more

September 11, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Seven Bridges & e-NIOS Partnership to Break the Biomarker Bottleneck

September 11, 2018 Cambridge, Mass. and Athens, Greece., Sept 11, 2018. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine... Read more

September 10, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships Product Launch

Seven Bridges announces the launch of largest pediatric data resource as a member of the Gabriella Miller Kids First Data Resource Center

September 10, 2018 Cambridge, Mass. Sept 10, 2018. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource... Read more

September 10, 2018 Informatics & Software M&A, Partnerships

Elsevier Closes its Acquisition of Aries Systems

NEW YORK, September 10, 2018 /PRNewswire/ — Elsevier, the global information analytics business specializing in science and health, today announced it has completed its acquisition of Aries Systems, a leader in scientific publication workflow solutions headquartered outside Boston, Massachusetts. Aries’ offerings are used by journals, books and other publications for manuscript submission, peer review, production tracking and eCommerce. “Elsevier’s... Read more

September 10, 2018 Environ, Ag./Food & Bev

IDEXX Pseudalert Test Accepted as Global ISO Standard

WESTBROOK, Maine, September 10, 2018—IDEXX Laboratories, Inc. (NASDAQ: IDXX), the global leader in rapid microbiological testing for water, today announced that the IDEXX Pseudalert® method has been published as the International Organization for Standardization (ISO) worldwide standard 16266-2 for the 24-hour detection of Pseudomonas aeruginosa in water. P. aeruginosa can cause life-threatening infections in hospitals... Read more

September 10, 2018 Chromatography Product Launch

New Product Introduction: KANEKA KanCapA 3G Affinity Sorbent

September 10, 2018 KANEKA♦ KanCapA 3G sorbent comprises a recombinant Protein A ligand covalently attached to a rigid cellulose matrix. This ensures stability over a high number of cycles and provides high flow performance at low pressure making the sorbent compatible with the process requirements for large scale mAb manufacture in both batch and continuous processing using... Read more

September 10, 2018 PR/Corporate

DefiniGEN strengthens Board with the appointment of Professor Sir John Savill

Cambridge, UK, 10th September 2018: DefiniGEN, the world leader in human iPSC differentiation and disease modelling, today announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board. Sir John will bring his expertise in translational science to DefiniGEN enabling the company to accelerate the development of new products and services which can... Read more

September 10, 2018 Microscopy Product Launch

Increase Efficiency and Accelerate Drug Discovery Research with Olympus NoviSight™ 3D Cell Analysis Software

September 10, 2018 3D imaging technology provides images of the cell cluster down to the nuclei while mitigating drug discovery risks Olympus Corporation today announced the U.S.-only launch of a new 3D cell analysis technology with ability to accurately analyze 3D cell cultures down to the nuclei, improving the reliability and accuracy of the entire... Read more

September 7, 2018 Lab Top-10 M&A, Partnerships

BD Statement on Divestiture of Advanced Bioprocessing Business

FRANKLIN LAKES, N.J., Sept. 7, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific: “The sale of our Advanced Bioprocessing business will create greater focus for our Life Sciences segment where BD... Read more